title: Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer.
abstract: Recent studies suggest that hereditary prostate cancer (PRCA) is a complex disease, involving multiple susceptibility genes and variable phenotypic expression. Through linkage analysis, potential prostate cancer susceptibility loci have been mapped to 3 regions on chromosome 1. To investigate the reported linkage to these regions, we conducted linkage studies on 144 PRCA families by using microsatellite markers in regions 1q24-25 (HPC1) and 1q42.2-43 (PCAP). We also examined the 1p36 (CAPB) region in 13 PRCA families with at least one case of brain cancer. No significant evidence of linkage to the HPC1 or PCAP region was found when the entire data set was analyzed. However, weak evidence for linkage to HPC1 was observed in the subset of families with male-to-male transmission (n=102; maximum multipoint nonparametric linkage [NPL] 1.99, P=.03). Weak evidence for linkage with heterogeneity within this subset was also observed (HLOD 1.21, P=.02), with approximately 20% of families linked. Although not statistically significant, suggestive evidence for linkage to PCAP was observed for the families (n=21) that met the three criteria of male-to-male transmission, average age of diagnosis <66 years, and >/=5 affected individuals (maximum multipoint NPL 1.45, P=.08). There was no evidence for linkage to CAPB in the brain cancer-prostate cancer subset. These results strengthen the argument that prostate cancer is a heterogeneous disease and that multiple genetic and environmental factors may be important for its etiology.
authors.affiliation: Department of Laboratory Medicine, Mayo Clinic/Foundation, 200 First Street, SW, Rochester, MN 55905, USA.
authors.forename: R
authors.initials: R
authors.lastname: Berry
authors.forename: D J
authors.initials: DJ
authors.lastname: Schaid
authors.forename: J R
authors.initials: JR
authors.lastname: Smith
authors.forename: A J
authors.initials: AJ
authors.lastname: French
authors.forename: J J
authors.initials: JJ
authors.lastname: Schroeder
authors.forename: S K
authors.initials: SK
authors.lastname: McDonnell
authors.forename: B J
authors.initials: BJ
authors.lastname: Peterson
authors.forename: Z Y
authors.initials: ZY
authors.lastname: Wang
authors.forename: J D
authors.initials: JD
authors.lastname: Carpten
authors.forename: S G
authors.initials: SG
authors.lastname: Roberts
authors.forename: D J
authors.initials: DJ
authors.lastname: Tester
authors.forename: M L
authors.initials: ML
authors.lastname: Blute
authors.forename: J M
authors.initials: JM
authors.lastname: Trent
authors.forename: S N
authors.initials: SN
authors.lastname: Thibodeau
mesh_terms: D000368:Aged; D001932:Brain Neoplasms / Q000235:genetics; D002874:Chromosome Mapping; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics*; D005260:Female; D018740:Genetic Heterogeneity; D020022:Genetic Predisposition to Disease / Q000235:genetics; D014644:Genetic Variation / Q000235:genetics; D006801:Humans; D008126:Lod Score; D008297:Male; D018895:Microsatellite Repeats / Q000235:genetics*; D008875:Middle Aged; D008957:Models, Genetic; D010375:Pedigree; D011471:Prostatic Neoplasms / Q000235:genetics*